title: Comparison of a rational vs. high throughput approach for rapid salt screening and selection.
abstract: In recent years, high throughput (HT) screening has become the most widely used approach for early phase salt screening and selection in a drug discovery/development setting. The purpose of this study was to compare a rational approach for salt screening and selection to those results previously generated using a HT approach. The rational approach involved a much smaller number of initial trials (one salt synthesis attempt per counterion) that were selected based on a few strategic solubility determinations of the free form combined with a theoretical analysis of the ideal solvent solubility conditions for salt formation. Salt screening results for sertraline, tamoxifen, and trazodone using the rational approach were compared to those previously generated by HT screening. The rational approach produced similar results to HT screening, including identification of the commercially chosen salt forms, but with a fraction of the crystallization attempts. Moreover, the rational approach provided enough solid from the very initial crystallization of a salt for more thorough and reliable solid-state characterization and thus rapid decision-making. The crystallization techniques used in the rational approach mimic larger-scale process crystallization, allowing smoother technical transfer of the selected salt to the process chemist.
authors.affiliation: Pfizer Global Research & Development, Eastern Point Road, Groton, CT, USA. benjamin.collman@abbott.com
authors.forename: Benjamin M
authors.initials: BM
authors.lastname: Collman
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Miller
authors.forename: Christopher
authors.initials: C
authors.lastname: Seadeek
authors.forename: Julie A
authors.initials: JA
authors.lastname: Stambek
authors.forename: Anthony C
authors.initials: AC
authors.lastname: Blackburn
mesh_terms: D003460:Crystallization / Q000379:methods*; D004355:Drug Stability; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D012492:Salts / Q000737:chemistry*; D012995:Solubility; D012997:Solvents / Q000737:chemistry*; D013678:Technology, Pharmaceutical / Q000379:methods; D013997:Time Factors; D014961:X-Ray Diffraction / Q000379:methods*
chemical_list: D004364:Pharmaceutical Preparations; D012492:Salts; D012997:Solvents